Costello Asset Management, INC
Position in EBS — Emergent BioSolutions Inc.
CIK 1760145
FEASTERVILLE, PA
Position in EBS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$3,352
+$32 QoQ
Shares Held
400
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#162
of 193 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Costello Asset Management, INC holds $146,843 across 7 Drug Manufacturers - Specialty & Generic names. EBS ranks #5 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PBH |
Prestige Consumer Healthcare Inc.
|
1,300 | $61,451 | |
| 2 | ZTS |
Zoetis Inc.
|
729 | $52,385 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
1,000 | $14,490 | |
| 4 | HLN |
Haleon plc
|
1,400 | $13,062 | |
| 5 | EBS |
Emergent BioSolutions Inc.
This page
|
400 | $3,352 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
10 | $1,685 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
17 | $418 |
All Filings in EBS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,352 | 400 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $3,320 | 400 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $4,944 | 400 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $3,528 | 400 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,552 | 400 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $1,944 | 400 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||